Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Details for Australian Patent Application No. 2011205217 (hide)

Owner Euro-Celtique SA

Inventors Wright, Curtis; Carpanzo, Anthony E.

Agent Allens Arthur Robinson

Pub. Number AU-A-2011205217

Parent 2008202531

Filing date 8 August 2011

Wipo publication date 25 August 2011

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

25 August 2011 Application Open to Public Inspection

  Published as AU-A-2011205217

25 August 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011205218-Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand

2011205216-Vegetation pruning device